Andrew Galler
Stock Analyst at Morgan Stanley
(0.56)
# 4,180
Out of 5,143 analysts
30
Total ratings
33.33%
Success rate
-15.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Equal-Weight | $34 → $36 | $35.25 | +2.13% | 14 | Nov 10, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $14.35 | +4.53% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $5.68 | +216.90% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $67.60 | -45.27% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $79.44 | -29.51% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $6.94 | +159.37% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $75.56 | -28.53% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $71.71 | -30.27% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.57 | +1,132.49% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $49.81 | +510.32% | 1 | Nov 9, 2021 |
Immunocore Holdings
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $34 → $36
Current: $35.25
Upside: +2.13%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $14.35
Upside: +4.53%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $5.68
Upside: +216.90%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $67.60
Upside: -45.27%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $79.44
Upside: -29.51%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $6.94
Upside: +159.37%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $75.56
Upside: -28.53%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $71.71
Upside: -30.27%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.57
Upside: +1,132.49%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $49.81
Upside: +510.32%